Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: steve brooks who wrote (7999)	2/6/1999 8:25:00 PM
From: Mike McFarland	Read Replies (2) \| Respond to of 56535

I wanted to steal the 8000th post:-) Forgive me...these stocks are most certainly not tradable! My largest holding is Cambridge NeuroScience, CNSI. The stock trades at 3/4ths on the OTC:bb, It is now just a tad above it's book value and has a market cap of 13M. The company turned an eight cent profit in the latest quarter...although that certainly is not the reason to buy the stock. This company is a micro biotech stock in the CNS/neuro area--and has a deal with Bayer for development of rhGGF2, recombinant human glial growth factor 2, for treatment of various CNS diseases, including multiple sclerosis, muscular dystrophy, and misc neuropathies. The deal is worth up to 26M over the next several years, so the cash burn, an important factor for these micro biotech stocks, is less of a factor here. biz.yahoo.com Under terms of the agreement, Bayer will be responsible for all development costs, including reimbursement of Cambridge NeuroScience's research costs for GGF2 and will receive exclusive worldwide manufacturing and marketing rights to the compound. In exchange, Cambridge NeuroScience may receive up to $26 million in cash and milestone payments, as well as royalties on sales of GGF2 products. You can see the list of leads here at the recap website. recap.com Doing queries on the recombinant site is a nice way to get a first approximation for the stocks you want to do some DD on. Let's do a quick query of diabetic+neuropathy, since a treatment for this could bring 1B in sales for the winner. recap.com Notice that another OTC:bb comes up, Neurobiolgical Technologies, NTII...that is my third largest holding, and I don't even own it for that reason, but rather the hope for an Alzheimer's dementia drug. If a person rushed out and bought these stocks based on my advice, he'd be a fool. But these are two of my best three ideas, and could be a good starting point for somebody bottomfishing in biotech. Mainly I just wanted to steal the 8000th post, and I had this in a folder ready to go, so I used it. Sorry for being off topic, but at least I own the stocks! --Mike